Autoantibodies in Primary Sjögren's Syndrome: New Insights into Mechanisms of Autoantibody Diversification and Disease Pathogenesis

References

• Jonsson R, Haga H -J, Gordon T P. Sjögren's syndrome. Arthritis and Allied Conditions, 14^th edn., W. Koopman. Lea and Febiger, Philadelphia 2000; 1826–1849
   Google Scholar
• McCluskey J, Farris A D, Keech C L, Purcell A W, Rischmueller M, Kinoshita G, Reynolds P, Gordon T P. Determinant spreading: lessons from animal models and human disease. Immunological Reviews 1998; 164: 209–229
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Moutsopoulos H, Balestrieri G, Bencivelli N, Bernstein R. M., et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340–347
   PubMed Web of Science ®Google Scholar
• Wahren-Herlenius M, Muller S. Isenberg Analysis of B-cell epitopes of the Ro/SS-A autoantigen. Immunology Today 1999; 20: 234–240
   PubMedGoogle Scholar
• Scofield R H, Farris A D, Horsfall A C, Harley J B. Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum 1999; 42: 199–209
   PubMedGoogle Scholar
• Gordon T, Topfer F, Keech C, Reynolds P, Chen W, Rischm-Ueller M, McCluskey J. How does autoimmunity to La and Ro initiate and spread?. Autoimmunity 1994; 18: 87–92
   PubMed Web of Science ®Google Scholar
• Farris A D, Keech C L, Gordon T P, McCluskey J. Epitope mimics and determinant spreading: pathways to autoimmunity. Cell Mol. Life Sci 2000; 57: 569–578
   PubMed Web of Science ®Google Scholar
• Reynolds P, Gordon T P, Purcell A W, Jackson D C, McCluskey J. Hierarchical self-tolerance to T cell determinants within the ubiquitous nuclear self antigen La (SS-B) permits induction of systemic autoimmunity in normal mice. J. Exp. Med. 1996; 184: 1–14
   PubMed Web of Science ®Google Scholar
• Farris A D, Keech C L, Gordon T P, McCluskey J. Immune tolerance to the nuclear antigen La and constitutive presentation of nuclear antigen by autoreactive B cells. J. Immunol., In press
   Google Scholar
• Ben-Chetrit E, Chan E K, Sullivan K F, Tan E M. A 52-kD protein is a novel component of the SSA-Ro antigen particle. J Exp. Med. 1988; 167: 1560–1571
   PubMed Web of Science ®Google Scholar
• Boire G, Gendron M, Monast N, Bastin B, Menard H A. Purification of antigenically intact Ro ribonucleoproteins: biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin. Exp. Immunol. 1995; 100: 489–498
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen L A, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp. Med. 1994; 179: 1317–1330
   PubMed Web of Science ®Google Scholar
• Beer R G, Rischmueller M, Coates T, Purcell A, Keech C, McCluskey J., et al. Non-precipitating anti-La(SS-B) autoantibodies in primary Sjögren's syndrome. Clin. Immunol. Immunopathol. 1996; 79: 314–318
   PubMedGoogle Scholar
• McCauliffe D P, Wang L, Satoh M, Reeves W H, Small D. Recombinant 52kDa Ro(SS-A) ELISA detects autoantibodies in Sjögren's syndrome that go undetected by conventional serologic assays. J. Rheumatol. 1997; 24: 860–866
   PubMed Web of Science ®Google Scholar
• Kinoshita G, Purcell A W, Keech C L, Farris A D, McCluskey J, Gordon T P. Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice. Clin. Exp. Immunol. 1999; 115: 268–274
   PubMed Web of Science ®Google Scholar
• Purcell A W, Kinoshita G, Rosen A, Todd A, Gething M -J, Gordon T P. Autoimmunity heats up - a role for endogenous heat shock proteins?. Arthritis Rheum 1999; 42(supp 1)S361, (abstract)
   Google Scholar
• Sato R, Srivastava P K. A mechanism for the specific immu-nogenicity of heat shock protein - chaperoned peptides. Science 1995; 269: 1585–1588
   PubMed Web of Science ®Google Scholar
• Castellino F, Boucher P E, Eichelberg K, Mayhew M, Roth-Man J E, Houghton A N, Germain R N. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 2000; 191: 1957–1964
   PubMed Web of Science ®Google Scholar
• Todryk S M, Melcher A A, Dalgleish A G, Vile R G. Heat shock proteins refine danger theory. Immunology 2000; 99: 334–337
   PubMed Web of Science ®Google Scholar
• Rischmueller M, Lester S, Chen Z, Champion G, Van Den Berg R, Beer R, Coates T, McCluskey J, Gordon T P. HLA Class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome (pSS). Clin. Exp. Immunol. 1998; 111: 365–371
   PubMed Web of Science ®Google Scholar
• Walport M J. Lupus, DNase and defective disposal of cellular debris. Nature Genetics 2000; 25: 135–136
   PubMed Web of Science ®Google Scholar
• Sumida T, Matsumoto I, Murata H, Namekawa T, Mat-Sumura R, Tomioka H, et al. TCR in Fassensitive T cells from labial salivary glands of patients with Sjögren's syndrome. J. Immunol. 1997; 158: 1020–1025
   PubMed Web of Science ®Google Scholar
• Kong L, Ogawa N, McGulf H S, Nakabayashi T, Sakata K, Masago R., et al. Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction. Clin. Immunol. Immun-opathol. 1998; 88: 133–144
   PubMedGoogle Scholar
• Rischmueller M, Scott J, Beroukas D, Gannot G, Fletcher D, Gordon T P, Fox P C. Salivary gland apoptosis in primary Sjögren's syndrome: a controlled study. Arthritis Rheum 1998; 41(supp. 1)S325, (abstract)
   Google Scholar
• Ohlsson M, Skarstein K, Bolstad A I, Johannessen A C, Jonsson R. Fas-induced apoptosis is a rare event in Sjögren's syndrome. Lab. Invest. 2001; 81: 95–105
   PubMed Web of Science ®Google Scholar
• Reveille J D. The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. Curr. Opin. Rheumatol. 1992; 4: 644–656
   PubMedGoogle Scholar
• Wilson R W, Provost T T, Bias W B, Alexander E L, Edlow D W, Hochberg M. C., et al. Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum 1984; 27: 1245–1253
   PubMed Web of Science ®Google Scholar
• Harley J B, Alexander E L, Bias W B, Fox O F, Provast T T, Yamagata H., et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986; 29: 196–206
   PubMed Web of Science ®Google Scholar
• Hamilton R G, Harley J B, Bias W B, Roebber M, Reichlin M, Hochberg M. C., et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31: 496–505
   PubMed Web of Science ®Google Scholar
• Bolstad A I, Wassmuth R, Haga H -J. HLA markers and clinical characteristics in primary Sjögren's syndrome. J. Rheumatol., In press
   Web of Science ®Google Scholar
• Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G., et al. Primary Sjögren's syndrome: role of the HLA-DRB 1*0301- 1501 heterozygotes. J. Rheumatol. 1998; 25: 900–905
   PubMed Web of Science ®Google Scholar
• Kang H I, Fei H M, Saito I, Sawada S, Chen S L, Yi D., et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J. Immunol. 1993; 150: 3615–3623
   PubMed Web of Science ®Google Scholar
• Reveille J D, Macleod M J, Whittington K, Arnett F C. Specific amino acid residues in the second hypervariable region of HLA- DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J. Immunol. 1991; 146: 3871–3876
   PubMed Web of Science ®Google Scholar
• Kerttula T O, Collin P, Polvi A, Korpela M, Partanen J, Maki M. Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB 1*0201. Alterations in circulating T cell receptor gamma/delta subsets. Arthritis. Rheum. 1996; 39: 1733–1739
   PubMedGoogle Scholar
• Harley J B, Reichlin M, Arnett F C, Alexander E L, Bias W B, Provost T T. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986; 232: 1145–1147
   PubMed Web of Science ®Google Scholar
• Fei H M, Kang H, Scharf S, Erlich H, Peebles C, Fox R. Specific HLA-DQ A and HLA-DRB 1 alleles confer susceptibility to Sjögren's syndrome and autoantibody production. J. Clin. Lab. Anal. 1991; 5: 382–391
   PubMed Web of Science ®Google Scholar
• Scofield R H, Harley J B. Association of anti-Ro/SS-A autoantibodies with glutamine in position 34 of DQA1 and leucine in position 26 of DQB1. Arthritis Rheum 1994; 37: 961–962
   PubMedGoogle Scholar
• Roitberg-Tambur A, Friedmann A, Safirman C, et al. Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Hum. Immunol. 1993; 36: 235–242
   PubMed Web of Science ®Google Scholar
• Nakken B, JR, Jonsson R, Bolstad A I. Polymorphims of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome. Arthritis Rheum 2001; 44: 638–646
   PubMed Web of Science ®Google Scholar
• Ricchiuti V, Isenberg D, Muller S. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome. J Autoimmun 1994; 7: 611–621
   PubMed Web of Science ®Google Scholar
• Nepom G T. Class II antigens and disease susceptibility. Annu. Rev. Med. 1995; 46: 17–25
   PubMed Web of Science ®Google Scholar
• Foster H, Walker D, Charles P, Kelly C, Cavanagh G, Griffiths I. Association of DR3 with susceptibility to and severity of primary Sjögren's syndrome in a family study. Br. J. Rheumatol. 1992; 31: 309–314
   PubMedGoogle Scholar
• MacSween R NM, Govidie R B, Anderson J R, Armstrong E, Murray M A, Mason D. K., et al. Occurrence of antibody to salivary duct epithelium in Sjögren's disease. Rheumatoid arthritis and other arthritides - a clinical and laboratory study. Ann. Rheum. Dis. 1967; 26: 402–411
   PubMed Web of Science ®Google Scholar
• Feltkamp T EW, Van Rossum A L. Antibodies to salivary duct cells and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases. Clin. Exp. Immunol. 1968; 3: 1–16
   PubMedGoogle Scholar
• Whaley K, Chisholm D M, Goudie R B, Downie W W, Dick W C, Boyle J. A., et al. Salivary duct autoantibody in Sjögren's syndrome: correlation with focal sialadenitis in the labial mucosa. Clin. Exp. Immunol. 1969; 4: 273–282
   Web of Science ®Google Scholar
• Goldblatt F, Beroukas D, Gillis D, Cavil D, Bradwell A, Rischmueller M, Gordon T P. Antibodies to AB blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms. Rheumatol 2000; 27: 2382–2388
   Web of Science ®Google Scholar
• Prakobphol A, Leffler H, Fischer S J. The high-molecular weight human mucin is the primary salivary carrier of ABH, Le a and Le b blood group antigens. Crit. Rev. Oral. Biol. Med. 1993; 4: 325–333
   PubMedGoogle Scholar
• Feist E, Kuckelkorn U, Dorner T, Donitz H, Scheffler S, Hiepe F., et al. Autoantibodies in primary Sjögren's syndrome are directed against proteosomal subunits of the alpha and beta type. Arthritis Rheum 1999; 42: 697–702
   PubMed Web of Science ®Google Scholar
• Inagaki Y, Jinno-Yoshida Y, Hamasaki Y, Ueki H. A novel autoantibody reactive with carbonic anhydrase in sera from patients with systemic lupus erythematosus and Sjögren's syndrome. Dermatol. Sci 1991; 2: 147–154
   PubMedGoogle Scholar
• Kino-Ohsaki J, Nishimori I, Morita M, Okazaki K, Yamamoto Y, Onishi S, Hollingsworth M A. Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis. Gastroenterology 1996; 110: 1579–1586
   PubMed Web of Science ®Google Scholar
• Henriksson G, Manthorpe R, Bredberg A. Antibodies to CD4 in primary Sjögren's syndrome. Rheumatology 2000; 39: 142–147
   PubMed Web of Science ®Google Scholar
• Heneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, et al. Identification of a-fodrin as a candidate autoan-tigen in primary Sjögren's syndrome. Science 1997; 276: 604–607
   PubMed Web of Science ®Google Scholar
• Zandbelt M, Degen W, Van de Putte L, van Venrooij W, van den Hoogen F. Anti-a-fodrin antibodies: not specific nor sensitive for Sjögren's syndrome. Arthritis Rheum 1999; 42(Supp 1)S142, (abstract)
   Google Scholar
• Fox R I. Sjögren's syndrome. Curr. Opin. Rheumatol. 1995; 7: 409–416
   PubMedGoogle Scholar
• Fox R I, Tornwall J, Maruyama T, Sterm M. Evolving concepts of diagnosis, pathogenesis and therapy of Sjögren's syndrome. Curr. Opin. Rheumatol. 1988; 10: 446–456
   Google Scholar
• Daniels T E, Whitcher J P. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis: analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994; 37: 869–877
   PubMed Web of Science ®Google Scholar
• Jonsson R, Kroneld U, Backman K, Magnusson B, Tarkowski A. Progression of sialadenitis in Sjögren's syndrome. Brit. J. Rheumatol. 1993; 32: 578–581
   PubMedGoogle Scholar
• Dawson L J, Smith P M, Moots R J, Field E A. Sjögren's syndrome - time for a new approach. Rheumatology 2000; 39: 234–237
   PubMed Web of Science ®Google Scholar
• Dawson L J, Christmas S E, Smith P M. An investigation of interactions between the immune system and stimulus secretion coupling in mouse submandibular acinar cells. A possible mechanism to account for reduced salivary flow rates associated with the onset of Sjögren's syndrome. Rheumatology 2000; 39: 1226–1233
   PubMed Web of Science ®Google Scholar
• Robinson C P, Brayer J, Yamachika S, Esch T R, Peck A B, Stewart C. A., et al. Transfer of human serum IgG to nonobese diabetic Igu mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc. Natl. Acad. Sci. USA 1998; 95: 7538–7543
   PubMed Web of Science ®Google Scholar
• Nguyen K HT, Brayer J, Cha S, Siggs S, Yasunari U, Hilal G, Peck A B, Humphreys-Beher M G. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum 2000; 43: 2297–2306
   PubMed Web of Science ®Google Scholar
• Bacman S, Sterin-Borda L, Camusso J J, Arana R, Hubscher O, Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin. Exp. Immunol. 1996; 104: 454–459
   PubMed Web of Science ®Google Scholar
• Bacman S, PerezLeiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest. Ophthalmol. Vis. Sci. 1998; 39: 151–156
   PubMed Web of Science ®Google Scholar
• Waterman S A, Gordon T P, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000; 43: 1647–1653
   PubMed Web of Science ®Google Scholar
• Van de Merwe J, Jamerling R, Arendsen E, Mulder D, Hooi-Jkaas H. Sjögren's syndrome in patients with interstitial cystitis. J. Rheumatol. 1993; 20: 962–966
   PubMed Web of Science ®Google Scholar
• Bachmeyer C, Zuber M, Dupont S, Blanch P, Dhote R, Mas J L. Adie syndrome as the initial sign of primary Sjögren's syndrome. Am J Ophthalmol 1997; 123: 691–692
   PubMed Web of Science ®Google Scholar
• Wright R A, Grant I A, Low P A. Autonomic neuropathy associated with sicca complex. J. Auton Nerv. Syst. 1999; 75: 70–76
   PubMedGoogle Scholar
• Katz J S, Houroupian D, Ross M A. Multisystem neuronal involvement and sicca complex: broadening the spectrum of complications. Muscle Nerve 1999; 22: 404–407
   PubMed Web of Science ®Google Scholar
• Andonopoulos A P, Christodoulou J, Ballas C, Bounas A. Alexopoulos D. Autonomic cardiovascular neuropathy in Sjögren's syndrome: a controlled study. J Rheumatol 1998; 25: 2385–2388
   PubMed Web of Science ®Google Scholar
• Hakala M, Niemela R K. Does autonomic nervous impairment have a role in pathophysiology of Sjögren's syndrome. Lancet 2000; 355: 1032–1033
   PubMed Web of Science ®Google Scholar
• Humphreys-Beher M G, Brayer J, Yamachika S, Peck A B, Jonsson R. An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand. J. Immunol. 1999; 49: 7–10
   PubMed Web of Science ®Google Scholar
• Van De Merwe J P, Arendsen H J. Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis. BJU International 2000; 85: 995–999
   PubMed Web of Science ®Google Scholar
• Gooin J C, Borda E, Leiros C, Storino R, Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J. Auton. Nerv. Syst. 1994; 47: 45–52
   PubMedGoogle Scholar
• Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A., et al. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin. Invest. 1990; 86: 1658–63
   PubMed Web of Science ®Google Scholar
• Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, et al. Patients with preeclampsia develop agonistic autoantibodies against angiotensin ATI receptor. J. Clin. Invest. 1999; 103: 945–52
   PubMed Web of Science ®Google Scholar